Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.68 |
| ▸ | PRKCG | P05129 | 2/20 | 0.68 |
| ▸ | PRKCB | P05771 | 2/20 | 0.68 |
| ▸ | PRKCA | P17252 | 2/20 | 0.68 |
| ▸ | PRKCH | P24723 | 2/20 | 0.68 |
| ▸ | PRKCI | P41743 | 2/20 | 0.68 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.68 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.68 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.68 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.68 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.68 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.66 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.66 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.66 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.66 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.66 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14842644 | 1.00 | PRKD3 (0.68) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14843034 | 1.00 | PRKD3 (0.68) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL18519898 | 1.00 | PRKD3 (0.68) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14843018 | 0.98 | PRKD3 (0.65) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL4401638 | 0.96 | PRKD3 (0.72) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL4547618 | 0.91 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14007343 | 0.91 | PRKD3 (0.56) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL133766 | 0.88 | USP2 (0.63) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10204069 | 0.88 | USP2 (0.63) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10566104 | 0.88 | USP2 (0.63) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170189438-A1 | DI- and Tri-Cationic Glycosylated Antitumor Ether Lipids, L-Gucosylated Gaels and Rhamnose-Linked Gaels as Cytotoxic Agents Against Epithelial Cancer Cells and Cancer Stem Cells | THE UNIV OF MANITOBA (CA) | 2017-07-06 | — | — | US | disclosed |
| US-20130237720-A1 | High-Purity Phospholipids | VASCULAR BIOGENICS LTD. (IL) | 2013-09-12 | — | — | US | disclosed |
| US-20030198614-A1 | Hair growers | SHISEIDO CO., LTD. (JP) | 2003-10-23 | — | — | US | disclosed |
| EP-1314417-A1 | HAIR GROWERS | Shiseido Co., Ltd. (JP) | 2003-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198614-A1 | Hair growers | EBP, FGF1, HSD17B7 | PRKD3 3266/4885PRKCG 3627/4885PRKCB 3302/4885 |
| US-20170189438-A1 | DI- and Tri-Cationic Glycosylated Antitumor Ether Lipids, L-Gucosylated Gaels and Rhamnose-Linked Gaels as Cytotoxic Agents Against Epithelial Cancer Cells and Cancer Stem Cells | UGCG, PNLIP, B3GAT3 | PRKD3 914/4885PRKCG 1343/4885PRKCB 990/4885 |
| US-20130237720-A1 | High-Purity Phospholipids | PHOSPHO1, SGMS1, SGMS2 | PRKD3 1185/4885PRKCG 525/4885PRKCB 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.